Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 32,700 shares at $134.70 ($4.4M) on 2021-05-12, disclosed to the SEC on 2021-05-13.
Open-market sale of $4.4M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.86 | 5,123 | $686K | 15.6% |
| 2 | $133.86 | 5,123 | $686K | 15.6% |
| 3 | $134.70 | 7,875 | $1.1M | 24.1% |
| 4 | $134.70 | 7,875 | $1.1M | 24.1% |
| 5 | $135.74 | 2,702 | $367K | 8.3% |
| 6 | $135.74 | 2,702 |
| $367K |
| 8.3% |
| 7 | $136.80 | 1,200 | $164K | 3.7% |
| 8 | $137.57 | 100 | $14K | 0.3% |
| Total | $134.69 avg | 32,700 | $4.4M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |